ProQR Therapeutics
PRQR
PRQR
46 hedge funds and large institutions have $60M invested in ProQR Therapeutics in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
12% less call options, than puts
Call options by funds: $655K | Put options by funds: $746K
36% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 14
Holders
46
Holding in Top 10
2
Calls
$655K
Puts
$746K
Top Buyers
| 1 | +$3.36M | |
| 2 | +$1.56M | |
| 3 | +$1.28M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.2M |
| 5 |
Millennium Management
New York
|
+$699K |
Top Sellers
| 1 | -$6.12M | |
| 2 | -$2.84M | |
| 3 | -$1.79M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$1.28M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$669K |